A Multicenter, Double-Blind, Randomized Study Evaluating De Novo Weekly and once Every 2 Week Darbepoetin Alfa Dosing for Correction of Anemia in Pediatric Subjects with Chronic Kidney Disease (Amgen Protocol #20050256)

Project: Research

Status	Finished
Effective start/end date	10/9/08 → 10/8/11

Project Details